slug (Cell Signaling Technology Inc)
Cell Signaling Technology Inc is a verified supplier 
Cell Signaling Technology Inc manufactures this product 
96
Structured Review
Cell Signaling Technology Inc
slug
Slug, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1357 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+slug/Slug+Rabbit+mAb/pmc13011209-84-71-73
Average 96 stars, based on 1357 article reviews
Slug, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1357 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+slug/Slug+Rabbit+mAb/pmc13011209-84-71-73
Average 96 stars, based on 1357 article reviews
slug - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Western Blot:Article Title: Ticagrelor reverses multidrug resistance in breast cancer by inhibiting PI3K/AKT/mTOR pathway and suppressing ABCB1 expression and function. Article Snippet: This is a PDF of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability.. This version will undergo additional copyediting, typesetting and review before it is published in its final form.. As such, this version is no longer the Accepted Manuscript, but it is not yet the definitive Version of Record; we are providing this early version to give early visibility of the article. Incubation:Article Title: Synergistic Anticancer Effects of Apatinib and PD-L1 Inhibition in Breast Cancer Article Snippet: Equal amounts of protein were separated by SDS‐PAGE and transferred onto PVDF membranes (Millipore, Massachusetts, U.S.A). .. The membranes were blocked with 5% non‐fat milk for 1 h at room temperature and then incubated overnight at 4 °C with the following primary antibodies purchased from Cell Signaling Technology (CST): anti‐ERK (CST‐4695, 1:1000), anti‐p‐ERK (CST‐4370, 1:1000), anti‐NF‐κB (CST‐8242, 1:1000), and Article Title: Synergistic Anticancer Effects of Apatinib and PD-L1 Inhibition in Breast Cancer. Article Snippet: Equal amounts of protein were separated by SDS-PAGE and transferred onto PVDF membranes (Millipore, Massachusetts, U.S.A). .. The membranes were blocked with 5% non-fat milk for 1 h at room temperature and then incubated overnight at 4 °C with the following primary antibodies purchased from Cell Signaling Technology (CST): anti-ERK (CST-4695, 1:1000), anti-p-ERK (CST-4370, 1:1000), 1 3 6 Page 2 of 12 Journal of Mammary Gland Biology and Neoplasia (2026) 31:6 anti-NF-κB (CST-8242, 1:1000), and Article Title: Activation of the PI3K/AKT pathway by EDIL3 induces EMT and promotes tumor progression in clear cell renal cell carcinoma. Article Snippet: tumor microenvironment, which collectively contribute to its aggressive biological behavior, Despite recent advances in imaging techniques (Shuch et al. 2024), many patients are diagnosed at advanced stages, resulting in a poor prognosis (Rathmell et al. 2022). this highlights a critical need to identify key regulators (Rosellini et al. 2023) that drive ccRCC initiation and progression and to elucidate the molecular mechanisms underlying tumor cell proliferation, invasion, and metastasis.. A deeper understanding of these processes is essential not only for improving early diagnosis but also for uncovering novel targets for mechanism-based therapeutic intervention.. Epithelial-mesenchymal transition (EMT) is a biological process in which cells change from an epithelial phenotype to a mesenchymal phenotype (Singh et al. 2018). other:Article Title: HOXB4 Promotes Bladder Cancer Progression in Part Through Transcriptional Activation of Smoothened Article Snippet: Primary antibodies obtained from Blocking Assay:Article Title: Activation of the PI3K/AKT pathway by EDIL3 induces EMT and promotes tumor progression in clear cell renal cell carcinoma. Article Snippet: tumor microenvironment, which collectively contribute to its aggressive biological behavior, Despite recent advances in imaging techniques (Shuch et al. 2024), many patients are diagnosed at advanced stages, resulting in a poor prognosis (Rathmell et al. 2022). this highlights a critical need to identify key regulators (Rosellini et al. 2023) that drive ccRCC initiation and progression and to elucidate the molecular mechanisms underlying tumor cell proliferation, invasion, and metastasis.. A deeper understanding of these processes is essential not only for improving early diagnosis but also for uncovering novel targets for mechanism-based therapeutic intervention.. Epithelial-mesenchymal transition (EMT) is a biological process in which cells change from an epithelial phenotype to a mesenchymal phenotype (Singh et al. 2018). |